CD33 and acute myeloid leukemia: Another preclinical studies of anti-CD-33 antibodies, a conjugate with DNA alkylation activity, possessing good antitumor effects in mouse model and AML cell lines, whose cytotoxic activity involved DNA damage, cell-cycle arrest, and apoptosis (33).